Adenovirus serotype 26 modified HIV vaccine (Janssen Vaccines & Prevention)

腺病毒血清-26修饰HIV疫苗

Report date: 2023/02/02 10:42:08

Base Information

Drug NameAdenovirus serotype 26 modified HIV vaccine (Janssen Vaccines & Prevention)
Drug Alias NameAdenovirus serotype-26 mosaic-4 HIV vaccine (Janssen)Ad26.Mos4.HIV (Janssen)Ad26 Mos4 HIV vaccine (Janssen)Tetravalent Ad26 Mos HIV (Janssen)Ad26 Mos4 HIV vaccine +[9] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsSexually Transmitted Diseases, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandUganda +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Vaccines & Prevention Bv
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceuticals IncJanssen Vaccines & Prevention Bv
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsSexually Transmitted Diseases, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A